Ana Flávia Spadaccini Silva de Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Flávia Spadaccini Silva de Oliveira has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Luciana Prado Maia
Graduate Program in Dentistry (PPGO), Evangelical University of Goiás (UNIEVANGELICA), Anápolis 75083-515, GO, Brazil
3 shared publications - Rodrigo Antonio Carvalho Andraus
Graduate Program in Rehabilitation Sciences, Pythagoras Unopar University (UNOPAR), Londrina 86038-440, PR, Brazil
3 shared publications - Regina Célia Poli-Frederico
North University of Paraná. Londrina. Paraná. Brazil
2 shared publications - Rodrigo Franco de Oliveira
Human Movement and Rehabilitation Graduate Program, Evangelical University of Goiás (UniEVANGELICA), Anápolis 75083-515, GO, Brazil
2 shared publications - Carlos Augusto Camillo
Laboratory for Studies of the Mucus Secretory System (LEAMS), Department of Physiotherapy, Faculty of Science and Technology, São Paulo State University (UNESP), Presidente Prudente 19060-900, Brazil
1 shared publication - Claudia Santos Oliveira
Graduate Program in Human Movement and Rehabilitation, Evangelical University of Goiás (UniEvangélica), Anápolis 75083-515, GO, Brazil
1 shared publication
Latest Publications
- Open Access
- 5 February 2026
- Published by Springer Nature in Lasers in Medical Science
- Vol. 41 (1) , 23
Laser photobiomodulation enhances cell viability and regenerative gene expression in oxidative-stressed muscle cells
Purpose: This study aimed to evaluate the effects of laser photobiomodulation therapy (LPT) on muscle cells subjected to oxidative stress. The primary objective was to determine whether LPT could preserve cell viability and modulate the expression of genes associated with muscle regeneration, specifically MyoD and myogenin , as well as the pro-inflammatory cytokine IL-6. Methods: C2C12 myoblasts were cultured and exposed to oxidative stress using hydrogen peroxide (H₂O₂) at a concentration of 50 µM for 1 h. Cells were then irradiated with LPT at wavelengths of 660–808 nm with fluences of 3, 5, and 10 J, applied either before (PRE-OS) or after (POST-OS) oxidative stress induction. Cell viability was assessed by the MTT assay, and gene expression was quantified using RT-qPCR. Results: Oxidative stress significantly reduced cell viability. LPT applied prior to OS with 660 nm (3 J) and 808 nm (3 and 10 J) attenuated this reduction. Notably, 10 J at 808 nm (PRE-OS) increased viability beyond control levels and markedly upregulated MyoD expression. Myogenin expression was also observed under 10 J PRE-OS conditions, while IL-6 expression was detected with 5 J at both wavelengths in PRE- and POST-OS groups. Conclusion: LPT demonstrated protective and regenerative effects on myoblasts under oxidative stress, preserving viability and enhancing regenerative gene expression. These findings support the potential of LPT as a therapeutic strategy for muscle injuries and disorders associated with oxidative stress.
- 5 February 2026
- Published by Springer Nature in Lasers in Medical Science
- Vol. 41 (1) , 23
Open AccessLaser photobiomodulation enhances cell viability and regenerative gene expression in oxidative-stressed muscle cells
Purpose: This study aimed to evaluate the effects of laser photobiomodulation therapy (LPT) on muscle cells subjected to oxidative stress. The primary objective was to determine whether LPT could preserve cell viability and modulate the expression of genes associated with muscle regeneration, specifically MyoD and myogenin , as well as the pro-inflammatory cytokine IL-6. Methods: C2C12 myoblasts were cultured and exposed to oxidative stress using hydrogen peroxide (H₂O₂) at a concentration of 50 µM for 1 h. Cells were then irradiated with LPT at wavelengths of 660–808 nm with fluences of 3, 5, and 10 J, applied either before (PRE-OS) or after (POST-OS) oxidative stress induction. Cell viability was assessed by the MTT assay, and gene expression was quantified using RT-qPCR. Results: Oxidative stress significantly reduced cell viability. LPT applied prior to OS with 660 nm (3 J) and 808 nm (3 and 10 J) attenuated this reduction. Notably, 10 J at 808 nm (PRE-OS) increased viability beyond control levels and markedly upregulated MyoD expression. Myogenin expression was also observed under 10 J PRE-OS conditions, while IL-6 expression was detected with 5 J at both wavelengths in PRE- and POST-OS groups. Conclusion: LPT demonstrated protective and regenerative effects on myoblasts under oxidative stress, preserving viability and enhancing regenerative gene expression. These findings support the potential of LPT as a therapeutic strategy for muscle injuries and disorders associated with oxidative stress.
- Open Access
- 12 January 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (1) , 88
Photobiomodulation Modulates the Response of Zoledronic-Acid-Treated Osteoblast-like SaOs-2 Cells: Implications for Bisphosphonate-Related Osteonecrosis
This study aimed to evaluate the effects of laser photobiomodulation (PBM) therapy in SaOs-2 osteosarcoma cells treated with zoledronic acid (ZA), a bisphosphonate, in vitro, mimicking a bisphosphonate-related osteonecrosis of the jaw (BRONJ) situation. Cells were treated with 100 μM ZA for 24 h and subjected to PBM using wavelengths of 660 nm and 808 nm at energy delivered of 1, 5, 10, and 20 J. After 24 h, metabolic activity, apoptosis, and BAX and BCL-2 gene expression were analyzed. Data were compared using one-way ANOVA followed by Tukey’s post hoc test (p < 0.05). ZA significantly reduced metabolic activity (p < 0.05), an effect attenuated by PBM at 808 nm with 1 J, while BCL-2 expression increased with 1 J at 660 nm and with 1 J and 20 J at 808 nm. However, PBM did not reverse ZA-induced apoptosis. In conclusion, PBM modulated the response of SaOs-2 osteoblastic cells treated with ZA in a wavelength- and dose-dependent manner. PBM at 808 nm and 1 J stimulated cell metabolic activity and upregulated BCL-2 expression, suggesting a potential protective effect against ZA-induced cytotoxicity.
- 12 January 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (1) , 88
Open AccessPhotobiomodulation Modulates the Response of Zoledronic-Acid-Treated Osteoblast-like SaOs-2 Cells: Implications for Bisphosphonate-Related Osteonecrosis
This study aimed to evaluate the effects of laser photobiomodulation (PBM) therapy in SaOs-2 osteosarcoma cells treated with zoledronic acid (ZA), a bisphosphonate, in vitro, mimicking a bisphosphonate-related osteonecrosis of the jaw (BRONJ) situation. Cells were treated with 100 μM ZA for 24 h and subjected to PBM using wavelengths of 660 nm and 808 nm at energy delivered of 1, 5, 10, and 20 J. After 24 h, metabolic activity, apoptosis, and BAX and BCL-2 gene expression were analyzed. Data were compared using one-way ANOVA followed by Tukey’s post hoc test (p < 0.05). ZA significantly reduced metabolic activity (p < 0.05), an effect attenuated by PBM at 808 nm with 1 J, while BCL-2 expression increased with 1 J at 660 nm and with 1 J and 20 J at 808 nm. However, PBM did not reverse ZA-induced apoptosis. In conclusion, PBM modulated the response of SaOs-2 osteoblastic cells treated with ZA in a wavelength- and dose-dependent manner. PBM at 808 nm and 1 J stimulated cell metabolic activity and upregulated BCL-2 expression, suggesting a potential protective effect against ZA-induced cytotoxicity.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Medicina do Esporte
- Vol. 29
DOES PHOTOBIOMODULATION IMPROVE MUSCLE PERFORMANCE AND RECOVERY? A SYSTEMATIC REVIEW
Photobiomodulation (PBM) appears to limit exercise-induced muscle damage, improve biochemical and functional recovery, and reduce inflammation and oxidative stress. This systematic review aimed to evaluate the effectiveness of photobiomodulation (PBM) in skeletal muscle recovery after exercise, addressing the different types of lasers and parameters used. Randomized clinical trials (RCTs) comparing the effects of PBM were included. The primary outcome evaluated was performance, and the secondary was inflammatory marker expression. The searches were conducted in March 2021. Fifteen RCTs that met the inclusion criteria were included. There was significant variability regarding the doses and wavelengths used, as well as in the types of lasers. However, in most studies, PBM promoted improvement of maximum voluntary contraction, better oxygen consumption, increased time to achieve exhaustion and fatigue, and decreased creatine kinase (CK), oxidative stress, and fatigue markers, mainly when used before exercise. Photobiomodulation applied before exercise, regardless of variations in doses and wavelengths, improves muscle performance and decreases levels of inflammation and fatigue markers. Evidence level II; Systematic review of level II studies.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Medicina do Esporte
- Vol. 29
Open AccessDOES PHOTOBIOMODULATION IMPROVE MUSCLE PERFORMANCE AND RECOVERY? A SYSTEMATIC REVIEW
Photobiomodulation (PBM) appears to limit exercise-induced muscle damage, improve biochemical and functional recovery, and reduce inflammation and oxidative stress. This systematic review aimed to evaluate the effectiveness of photobiomodulation (PBM) in skeletal muscle recovery after exercise, addressing the different types of lasers and parameters used. Randomized clinical trials (RCTs) comparing the effects of PBM were included. The primary outcome evaluated was performance, and the secondary was inflammatory marker expression. The searches were conducted in March 2021. Fifteen RCTs that met the inclusion criteria were included. There was significant variability regarding the doses and wavelengths used, as well as in the types of lasers. However, in most studies, PBM promoted improvement of maximum voluntary contraction, better oxygen consumption, increased time to achieve exhaustion and fatigue, and decreased creatine kinase (CK), oxidative stress, and fatigue markers, mainly when used before exercise. Photobiomodulation applied before exercise, regardless of variations in doses and wavelengths, improves muscle performance and decreases levels of inflammation and fatigue markers. Evidence level II; Systematic review of level II studies.